ALCON LABORATORIES (U.K.) LIMITED

Company Registration Number:
00968373 (England and Wales)

Unaudited statutory accounts for the year ended 31 December 2024

Period of accounts

Start date: 1 January 2024

End date: 31 December 2024

ALCON LABORATORIES (U.K.) LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2024

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

ALCON LABORATORIES (U.K.) LIMITED

Directors' report period ended 31 December 2024

The directors present their report with the financial statements of the company for the period ended 31 December 2024

Political and charitable donations

The Company made no political or charitable contributions during the year (2023: £nil).



Directors

The directors shown below have held office during the whole of the period from
1 January 2024 to 31 December 2024

Roy Henry
Xavier Romeu


The director shown below has held office during the period of
12 April 2024 to 31 December 2024

Olga Kostetskaya


Secretary Rebecca Weston

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
16 July 2025

And signed on behalf of the board by:
Name: Xavier Romeu
Status: Director

ALCON LABORATORIES (U.K.) LIMITED

Profit And Loss Account

for the Period Ended 31 December 2024

2024 2023


£

£
Turnover: 0 0
Cost of sales: 0 0
Gross profit(or loss): 0 0
Distribution costs: 0 0
Administrative expenses: ( 27 ) ( 42 )
Other operating income: 0 0
Operating profit(or loss): (27) (42)
Interest receivable and similar income: 767 760
Interest payable and similar charges: 0 0
Profit(or loss) before tax: 740 718
Tax: ( 185 ) ( 169 )
Profit(or loss) for the financial year: 555 549

ALCON LABORATORIES (U.K.) LIMITED

Balance sheet

As at 31 December 2024

Notes 2024 2023


£

£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets:   0 0
Tangible assets:   0 0
Investments:   0 0
Total fixed assets: 0 0
Current assets
Stocks:   0 0
Debtors: 3 10,000 10,109
Cash at bank and in hand: 3,073 2,368
Investments:   0 0
Total current assets: 13,073 12,477
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: 4 ( 286 ) ( 245 )
Net current assets (liabilities): 12,787 12,232
Total assets less current liabilities: 12,787 12,232
Creditors: amounts falling due after more than one year:   0 0
Provision for liabilities: 0 0
Accruals and deferred income: 0 0
Total net assets (liabilities): 12,787 12,232
Capital and reserves
Called up share capital: 9,100 9,100
Share premium account: 0 0
Other reserves: 0 0
Profit and loss account: 3,687 3,132
Total Shareholders' funds: 12,787 12,232

The notes form part of these financial statements

ALCON LABORATORIES (U.K.) LIMITED

Balance sheet statements

For the year ending 31 December 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 16 July 2025
and signed on behalf of the board by:

Name: Xavier Romeu
Status: Director

The notes form part of these financial statements

ALCON LABORATORIES (U.K.) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

ALCON LABORATORIES (U.K.) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

  • 2. Employees

    2024 2023
    Average number of employees during the period 0 0

ALCON LABORATORIES (U.K.) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

3. Debtors

2024 2023
£ £
Trade debtors 10,000 10,109
Prepayments and accrued income 0 0
Other debtors 0 0
Total 10,000 10,109
Debtors due after more than one year: 0 0

ALCON LABORATORIES (U.K.) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

4. Creditors: amounts falling due within one year note

2024 2023
£ £
Bank loans and overdrafts 0 0
Amounts due under finance leases and hire purchase contracts 0 0
Trade creditors 286 245
Taxation and social security 0 0
Accruals and deferred income 0 0
Other creditors 0 0
Total 286 245